Head of Investor Relations
Xeris Biopharma Holdings, Inc. (XERS)Equibles does not estimate personal net worth.
Get an email with a short summary when Xeris Biopharma Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get XERS alertsChristy Barnett is recorded as Head of Investor Relations at Xeris Biopharma Holdings, Inc. (XERS). Christy Barnett has spoken on 1 earnings call across 1 company, most recently for Xeris Biopharma Holdings, Inc. on November 5, 2026. Xeris Biopharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Xeris Biopharma Holdings, Inc. includes John P. Shannon (CEO and Board Member), John Shannon (CEO, Chairman, COO and Board Member), Marla S. Persky (Chairman) and 7 others.
“Good morning, everyone, and welcome to Zaris Biopharma's third quarter 2026 Financial Results Conference Call. Earlier this morning, we issued a press release detailing our third quarter, 2026 financial and operating results.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
